Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases Journal Article
| Authors: | Imber, B. S.; Young, R. J.; Beal, K.; Reiner, A. S.; Giantini-Larsen, A. M.; Krebs, S.; Yang, J. T.; Aramburu-Nunez, D.; Cohen, G. N.; Brennan, C.; Tabar, V.; Moss, N. S. |
| Article Title: | Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases |
| Abstract: | Background: Salvage of recurrent previously irradiated brain metastases (rBrM) is a significant challenge. Resection without adjuvant re-irradiation is associated with a high local failure rate, while reirradiation only partially reduces failure but is associated with greater radiation necrosis risk. Salvage resection plus Cs131 brachytherapy may offer dosimetric and biologic advantages including improved local control versus observation, with reduced normal brain dose versus re-irradiation, however data are limited. Methods: A prospective registry of consecutive patients with post-stereotactic radiosurgery (SRS) rBrM undergoing resection plus implantation of collagen-matrix embedded Cs131 seeds (GammaTile, GT Medical Technologies) prescribed to 60 Gy at 5 mm from the cavity was analyzed. Results: Twenty patients underwent 24 operations with Cs131 implantation in 25 tumor cavities. Median maximum preoperative diameter was 3.0 cm (range 1.1–6.3). Gross- or near-total resection was achieved in 80% of lesions. A median of 16 Cs131 seeds (range 6–30), with a median air-kerma strength of 3.5 U/seed were implanted. There was one postoperative wound dehiscence. With median follow-up of 1.6 years for survivors, two tumors recurred (one in-field, one marginal) resulting in 8.4% 1-year progression incidence (95%CI = 0.0–19.9). Radiographic seed settling was identified in 7/25 cavities (28%) 1.9–11.7 months post-implantation, with 1 case of distant migration (4%), without clinical sequelae. There were 8 cases of radiation necrosis, of which 4 were symptomatic. Conclusions: With > 1.5 years of follow-up, intraoperative brachytherapy with commercially available Cs131 implants was associated with favorable local control and toxicity profiles. Weak correlation between preoperative tumor geometry and implanted tiles highlights a need to optimize planning criteria. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| Keywords: | treatment outcome; retrospective studies; brain tumor; brain neoplasms; neoplasm recurrence, local; pathology; radiation injury; retrospective study; necrosis; tumor recurrence; radiosurgery; collagen; radiation injuries; brachytherapy; biological product; biological products; adverse event; complication; cesium; procedures; re-irradiation; cesium radioisotopes; humans; human; cesium-131 |
| Journal Title: | Journal of Neuro-Oncology |
| Volume: | 159 |
| Issue: | 3 |
| ISSN: | 0167-594X |
| Publisher: | Springer |
| Date Published: | 2022-09-01 |
| Start Page: | 609 |
| End Page: | 618 |
| Language: | English |
| DOI: | 10.1007/s11060-022-04101-9 |
| PUBMED: | 35896906 |
| PROVIDER: | scopus |
| PMCID: | PMC9328626 |
| DOI/URL: | |
| Notes: | Article -- Erratum issued, see DOI: 10.1007/s11060-022-04121-5 -- Export Date: 3 October 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work